Baxter to sell division for $4.2 billion

Deerfield-based Baxter International Inc. Monday said it has signed a definitive agreement to divest its BioPharma Solutions business to Advent International, one of the largest global private equity investors, and Warburg Pincus, a leading global growth investor.

Related posts